Skip to content

How sourdough bread compared with white bread affects blood sugar, digestion and appetite in adults

The acute glycaemic, digestive and appetite response to sourdough bread versus white bread: a randomised crossover trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11866792
Enrollment
30
Registered
2026-03-19
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial glycaemic response and metabolic health in adults with and without increased metabolic risk Nutritional, Metabolic, Endocrine

Interventions

This is a randomised, controlled, crossover study comparing two bread interventions: sourdough bread (intervention) and white/yeast bread (control). Participants will be randomised to the order in whi

Sponsors

University College Dublin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 20–45 years 2. Eligible for one of two cohorts: 2.1. Metabolically healthy adults, or 2.2. Adults with body mass index =30 kg/m² (metabolic health risk cohort) 3. Willing and able to attend two full-day (8-hour) study visits separated by =7 days 4. Willing to consume the provided bread test meals and to wear a glucose sensor for blood glucose monitoring 5. Able to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Diagnosed diabetes or other clinically significant metabolic disease 2. Use of medication known to affect glucose metabolism (e.g., glucose-lowering drugs, systemic corticosteroids) 3. Coeliac disease or wheat/gluten allergy/intolerance, or other food allergy relevant to the test breads 4. Gastrointestinal disease or major gastrointestinal surgery (excluding uncomplicated appendectomy) 5. Pregnancy or breastfeeding 6. Current smoker or high alcohol intake (as defined by the study team) 7. Acute illness at the time of study visits 8. Any condition that, in the investigator’s opinion, makes participation unsafe or affects study outcomes

Countries

Ireland

Contacts

Public ContactEmma Feeney
emma.feeney@ucd.ie+353 (0)17162247

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 4, 2026